Consultant (Interim Controller)
Current- Interim Controller at FibroGen Publicly trading biotech company with commercial product sales and several phase 3 clinical trials
- Prepared quarterly financial statements
- Managed month-end close process including revenue recognition, stock-based compensation, payroll, clinical trial and CMC accruals, consolidation
- Onboarded new Controller and helped to restructure the teamInterim Controller at NGM Biopharmaceuticals Publicly trading biotech company with several phase 1 and 2 clinical trials
- Managed month-end close process including revenue recognition, payroll, clinical trial and CMC accruals, allocations and foreign entity consolidation
- Assisted with implementation of SOX 404(b) internal controls